176 related articles for article (PubMed ID: 2551761)
1. Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects.
Lehtinen JM; Uusitupa M; Siitonen O; Pyörälä K
Diabetes; 1989 Oct; 38(10):1307-13. PubMed ID: 2551761
[TBL] [Abstract][Full Text] [Related]
2. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten-year follow-up from the diagnosis.
Töyry JP; Niskanen LK; Mäntysaari MJ; Länsimies EA; Uusitupa MI
Diabetes; 1996 Mar; 45(3):308-15. PubMed ID: 8593935
[TBL] [Abstract][Full Text] [Related]
3. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus.
Partanen J; Niskanen L; Lehtinen J; Mervaala E; Siitonen O; Uusitupa M
N Engl J Med; 1995 Jul; 333(2):89-94. PubMed ID: 7777034
[TBL] [Abstract][Full Text] [Related]
4. Divergent development of autonomic and peripheral somatic neuropathies in NIDDM.
Töyry JP; Partanen JV; Niskanen LK; Länsimies EA; Uusitupa MI
Diabetologia; 1997 Aug; 40(8):953-8. PubMed ID: 9267991
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II (noninsulin-dependent) diabetes.
Ratzmann KP; Raschke M; Gander I; Schimke E
J Diabet Complications; 1991; 5(1):1-5. PubMed ID: 1830312
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of peripheral neuropathy in newly diagnosed patients with non-insulin-dependent diabetes mellitus.
Weerasuriya N; Siribaddana S; Wijeweera I; Dissanayeka A; Wijesekera J; Fernando DJ
Ceylon Med J; 1998 Mar; 43(1):19-21. PubMed ID: 9624839
[TBL] [Abstract][Full Text] [Related]
7. Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population.
Harris M; Eastman R; Cowie C
Diabetes Care; 1993 Nov; 16(11):1446-52. PubMed ID: 8299433
[TBL] [Abstract][Full Text] [Related]
8. Clinical and electrophysiological correlations in type 2 diabetes mellitus at diagnosis.
Rota E; Quadri R; Fanti E; Poglio F; Paolasso I; Ciaramitaro P; Cossa FM; Cocito D
Diabetes Res Clin Pract; 2007 Apr; 76(1):152-4. PubMed ID: 16962681
[TBL] [Abstract][Full Text] [Related]
9. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study.
Dyck PJ; Kratz KM; Karnes JL; Litchy WJ; Klein R; Pach JM; Wilson DM; O'Brien PC; Melton LJ; Service FJ
Neurology; 1993 Apr; 43(4):817-24. PubMed ID: 8469345
[TBL] [Abstract][Full Text] [Related]
10. High prevalence and severity of cardiac autonomic neuropathy in Vietnamese diabetic patients.
Thi NN; Paries J; Attali JR; Valensi P
Diabet Med; 2005 Aug; 22(8):1072-8. PubMed ID: 16026375
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance.
Laitinen T; Lindström J; Eriksson J; Ilanne-Parikka P; Aunola S; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M
Diabet Med; 2011 Jun; 28(6):699-704. PubMed ID: 21388444
[TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction in peripheral nerves.
Eriksson KF; Nilsson H; Lindgärde F; Osterlin S; Dahlin LB; Lilja B; Rosén I; Sundkvist G
Diabet Med; 1994 Apr; 11(3):279-85. PubMed ID: 8033527
[TBL] [Abstract][Full Text] [Related]
13. Changes in autonomic nervous function during the 4-year follow-up in middle-aged diabetic and nondiabetic subjects initially free of coronary heart disease.
Mustonen J; Uusitupa M; Mäntysaari M; Länsimies E; Pyörälä K; Laakso M
J Intern Med; 1997 Mar; 241(3):227-35. PubMed ID: 9104436
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis and standard tests of heart-rate variation in newly diagnosed IDDM patients.
Ziegler D; Dannehl K; Volksw D; Mühlen H; Spüler M; Gries FA
Diabetes Care; 1992 Jul; 15(7):908-11. PubMed ID: 1516513
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population.
Boulton AJ; Knight G; Drury J; Ward JD
Diabetes Care; 1985; 8(2):125-8. PubMed ID: 3996169
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for autonomic and somatic nerve dysfunction in different stages of glucose tolerance.
Dimova R; Tankova T; Guergueltcheva V; Tournev I; Chakarova N; Grozeva G; Dakovska L
J Diabetes Complications; 2017 Mar; 31(3):537-543. PubMed ID: 27894750
[TBL] [Abstract][Full Text] [Related]
17. [Study of the onset and progression of peripheral neuropathy and hypertension in NIDDM].
Jarmuzewska EA; Ghidoni A
Minerva Med; 2000; 91(1-2):1-15. PubMed ID: 10858728
[TBL] [Abstract][Full Text] [Related]
18. Correlations among autonomic, sensory, and motor neural function tests in untreated non-insulin-dependent diabetic individuals.
Pfeifer MA; Weinberg CR; Cook DL; Reenan A; Halar E; Halter JB; LaCava EC; Porte D
Diabetes Care; 1985; 8(6):576-84. PubMed ID: 4075943
[TBL] [Abstract][Full Text] [Related]
19. Monofilament insensitivity and small and large nerve fiber symptoms in impaired fasting glucose.
Ylitalo KR; Herman WH; Harlow SD
Prim Care Diabetes; 2013 Dec; 7(4):309-13. PubMed ID: 23896181
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and risk factors of somatic and autonomic neuropathy in prediabetic and diabetic patients.
Hsu WC; Yen AM; Liou HH; Wang HC; Chen TH
Neuroepidemiology; 2009; 33(4):344-9. PubMed ID: 19887841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
